Merck & Co., Inc. (MRK)
147.74
+0.79
(+0.54%)
USD |
NYSE |
Nov 13, 16:00
147.74
0.00 (0.00%)
After-Hours: 17:03
Merck EPS Diluted (Quarterly) : 2.044 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.044 |
| June 30, 2026 | -0.5405 |
| March 31, 2026 | -1.715 |
| December 31, 2025 | 1.191 |
| September 30, 2025 | 2.316 |
| June 30, 2025 | 1.762 |
| March 31, 2025 | 2.007 |
| December 31, 2024 | 1.475 |
| September 30, 2024 | 1.242 |
| June 30, 2024 | 2.144 |
| March 31, 2024 | 1.872 |
| December 31, 2023 | -0.484 |
| September 30, 2023 | 1.864 |
| June 30, 2023 | -2.353 |
| March 31, 2023 | 1.106 |
| December 31, 2022 | 1.184 |
| September 30, 2022 | 1.278 |
| June 30, 2022 | 1.553 |
| March 31, 2022 | 1.698 |
| December 31, 2021 | 1.482 |
| September 30, 2021 | 1.801 |
| June 30, 2021 | 0.6083 |
| March 31, 2021 | 1.251 |
| December 31, 2020 | -0.8277 |
| September 30, 2020 | 1.159 |
| Date | Value |
|---|---|
| June 30, 2020 | 1.184 |
| March 31, 2020 | 1.264 |
| December 31, 2019 | 0.9211 |
| September 30, 2019 | 0.7391 |
| June 30, 2019 | 1.03 |
| March 31, 2019 | 1.120 |
| December 31, 2018 | 0.69 |
| September 30, 2018 | 0.73 |
| June 30, 2018 | 0.63 |
| March 31, 2018 | 0.27 |
| December 31, 2017 | -0.39 |
| September 30, 2017 | -0.02 |
| June 30, 2017 | 0.71 |
| March 31, 2017 | 0.56 |
| December 31, 2016 | -0.22 |
| September 30, 2016 | 0.78 |
| June 30, 2016 | 0.43 |
| March 31, 2016 | 0.40 |
| December 31, 2015 | 0.35 |
| September 30, 2015 | 0.64 |
| June 30, 2015 | 0.24 |
| March 31, 2015 | 0.33 |
| December 31, 2014 | 2.54 |
| September 30, 2014 | 0.31 |
| June 30, 2014 | 0.68 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
| Pfizer Inc. | 0.5637 |
| Bristol Myers Squibb Co. | 1.053 |
| Abbott Laboratories | 0.5294 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.067B |
| Revenue (Quarterly) | 18.12B |
| Total Expenses (Quarterly) | 13.06B |
| Enterprise Value | 406.57B |
| Gross Profit Margin (Quarterly) | 71.65% |
| Profit Margin (Quarterly) | 27.96% |
| Earnings Yield | 0.66% |
| Operating Earnings Yield | 3.38% |
| Normalized Earnings Yield | 2.022 |